Literature DB >> 9672641

Antigenicity of VP60 structural protein of rabbit haemorrhagic disease virus.

E Viaplana1, J Plana, A Villaverde.   

Abstract

Five overlapping segments of the VP60 capsid protein gene of rabbit haemorrhagic disease virus have been expressed in E. coli under the control of the T7 RNA polymerase. After purification, the antigenicity of these denatured protein segments has been studied by reactivity with sera from both naturally infected and vaccinated animals in Western blot analysis. The amino terminus segments of the protein (comprising the first 175 amino acids) are highly reactive with the tested sera, between 10 and 100 fold more than any of the segments reproducing the carboxy half of VP60, which is believed to be solvent-exposed in the virus particles. These results strongly suggest that the antigenic structure of the carboxy moiety of VP60 is mainly based on conformation-dependent B-cell epitopes whereas the amino terminal region of VP60 contains continuous antigenic determinants for the immune response elicited during both virus infection and exposure to the inactivated vaccine.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9672641     DOI: 10.1007/s007050050201

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  3 in total

1.  The capsid gene of feline calicivirus contains linear B-cell epitopes in both variable and conserved regions.

Authors:  A D Radford; K Willoughby; S Dawson; C McCracken; R M Gaskell
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Identification of Genogroup I and Genogroup II broadly reactive epitopes on the norovirus capsid.

Authors:  Tracy Dewese Parker; Noritoshi Kitamoto; Tomoyuki Tanaka; Anne M Hutson; Mary K Estes
Journal:  J Virol       Date:  2005-06       Impact factor: 5.103

3.  Analysis of genetic variability and phylogenetic analysis of selected Czech and French strains of rabbit haemorrhagic disease virus (RHDV).

Authors:  Beata Hukowska-Szematowicz; Beata Tokarz-Deptuła; Wiesław Deptuła
Journal:  J Appl Genet       Date:  2013-02-23       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.